Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 12 » default

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy


Archive: Volume 12, 2019

Assessment of insulin sensitivity and secretion in patients with fibrocalculous pancreatic diabetes

Aiswarya Y, Shivaprasad C, Anish K, Sridevi A, Anupam B, Amit G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:779-788

Published Date: 22 May 2019

Immunogenetics of new onset diabetes after transplantation in Kuwait

Jahromi M, Al-Otaibi T, Othman N, Gheith O, Mahmoud T, Nair P, Halim MA, Nampoory N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:731-742

Published Date: 20 May 2019

Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis [Corrigendum]

Liu M, Huang Y, Huang Z, Huang Q, Guo X, Wang Y, Deng W, Huang Z, Li T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:729-730

Published Date: 22 May 2019

An automatic diagnostic system based on deep learning, to diagnose hyperlipidemia

Zhang Q, Liu Y, Liu G, Zhao G, Qu Z, Yang W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:637-645

Published Date: 3 May 2019

Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients

Bakr Zaki M, Abulsoud AI, Elsisi AM, Doghish AS, Mansour OAE, Amin AI, Elrebehy MA, Mohamed MY, Goda MA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:601-611

Published Date: 6 May 2019

Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study

Rezaei M, Valiee S, Tahan M, Ebtekar F, Ghanei Gheshlagh R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:589-599

Published Date: 1 May 2019

The association between cardiac autonomic neuropathy and diabetes control

Vasheghani M, Sarvghadi F, Beyranvand MR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:581-587

Published Date: 30 April 2019

Prevalence of metabolic syndrome in dialysis and transplant patients

AlShelleh S, AlAwwa I, Oweis A, AlRyalat SA, Al-Essa M, Saeed I, Alhawari HH, Alzoubi KH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:575-579

Published Date: 29 April 2019

Anti-inflammatory and angiogenic effects of exercise training in cardiac muscle of diabetic mice

Broderick TL, Sennott JM, Gutkowska J, Jankowski M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:565-573

Published Date: 26 April 2019

Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach

Frost F, Dyce P, Ochota A, Pandya S, Clarke T, Walshaw MJ, Nazareth DS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:545-552

Published Date: 26 April 2019

Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers

Zahran AM, Sayed SK, Abd El Hafeez HA, Khalifa WA, Mohamed NA, Hetta HF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:485-493

Published Date: 12 April 2019

Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis

Liu M, Huang Y, Huang Z, Huang Q, Guo X, Wang Y, Deng W, Huang Z, Li T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:477-484

Published Date: 11 April 2019

Prevalence of abnormal glucose homeostasis in Chinese patients with non-transfusion-dependent thalassemia

Luo Y, Bajoria R, Lai Y, Pan H, Li Q, Zhang Z, Yang P, Chatterjee R, Liang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:457-468

Published Date: 11 April 2019

Low-dose computed tomography of urolithiasis in obese patients: a feasibility study to evaluate image reconstruction algorithms

Chang DH, Slebocki K, Khristenko E, Herden J, Salem J, Große Hokamp N, Mammadov K, Hellmich M, Kabbasch C

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:439-445

Published Date: 5 April 2019

Genetic variants linked to T2DM risk in Kurdish populations

Golsheh S, Keshavarzi F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:431-437

Published Date: 5 April 2019

Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions

Kratochvilova H, Lacinova Z, Klouckova J, Kavalkova P, Cinkajzlova A, Trachta P, Krizova J, Benes M, Dolezalova K, Fried M, Vlasakova Z, Pelikanova T, Spicak J, Mraz M, Haluzik M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:423-430

Published Date: 28 March 2019

Resveratrol affects hepatic gluconeogenesis via histone deacetylase 4

Zhao H, Shu L, Huang W, Song G, Ma H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:401-411

Published Date: 25 March 2019

Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus

Elsehmawy AAEW, El-Toukhy SE, Seliem NMA, Moustafa RS, Mohammed DS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:383-389

Published Date: 22 March 2019

Increase in mast cell marker expression in the synovium of obese patients with osteoarthritis of the knee

Uchida K, Takano S, Inoue G, Iwase D, Aikawa J, Takata K, Tazawa R, Kawakubo A, Sekiguchi H, Takaso M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:377-382

Published Date: 21 March 2019

Galectin-3 as a prognostic biomarker for diabetic nephropathy

Hodeib H, Hagras MM, Abdelhai D, Watany MM, Selim A, Tawfik MA, Elsebaey MA, Elshweikh SA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:325-331

Published Date: 13 March 2019

Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease

Soleimani D, Ranjbar G, Rezvani R, Goshayeshi L, Razmpour F, Nematy M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:315-324

Published Date: 12 March 2019

Measurement of diabetes, prediabetes and their associated risk factors in Myanmar 2014

Latt TS, Zaw KK, Ko K, Hlaing MM, Ohnmar M, Oo ES, Thein KMM, Yuasa M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:291-298

Published Date: 4 March 2019

Diabetic muscle infarction: often misdiagnosed and mismanaged

Verjee MA, Abdelsamad NA, Qureshi S, Malik RA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:285-290

Published Date: 5 March 2019

ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation with insulin resistance in obesity

Vincent V, Thakkar H, Aggarwal S, Mridha AR, Ramakrishnan L, Singh A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:275-284

Published Date: 25 February 2019

Identification of the MC4R start lost mutation in a morbidly obese Brazilian patient

Fonseca ACP, Abreu GM, Zembrzuski VM, Campos Junior M, Carneiro JRI, Magno FCCM, Rosado EL, Nogueira Neto JF, Cabello GMK, Cabello PH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:257-266

Published Date: 21 February 2019

Interaction between dietary patterns and TCF7L2 polymorphisms on type 2 diabetes mellitus among Uyghur adults in Xinjiang Province, China

Cai J, Zhang Y, Nuli R, Zhang Y, Abudusemaiti M, Kadeer A, Tian X, Xiao H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:239-255

Published Date: 14 February 2019

PEARLS randomized lifestyle trial in pregnant Hispanic women with overweight/obesity: gestational weight gain and offspring birthweight

Trak-Fellermeier MA, Campos M, Meléndez M, Pomeroy J, Palacios C, Rivera-Viñas J, Méndez K, Febo I, Willett W, Gillman MW, Franks PW, Joshipura K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:225-238

Published Date: 18 February 2019

Cardioprotective effects of a ruthenium (II) Schiff base complex in diet-induced prediabetic rats

Mabuza LP, Gamede MW, Maikoo S, Booysen IN, Ngubane PS, Khathi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:217-223

Published Date: 14 February 2019

Canagliflozin review – safety and efficacy profile in patients with T2DM

Jakher H, Chang TI, Tan M, Mahaffey KW

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:209-215

Published Date: 1 February 2019

Leptin resistance: underlying mechanisms and diagnosis

Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:191-198

Published Date: 25 January 2019

Analysis of the diet quality and dietary habits of children and adolescents with type 1 diabetes

Dłużniak-Gołaska K, Panczyk M, Szostak-Węgierek D, Szypowska A, Sińska B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:161-170

Published Date: 17 January 2019

Elevated free fatty acid level is associated with insulin-resistant state in nondiabetic Chinese people

Xin YL, Wang Y, Chi J, Zhu X, Zhao H, Zhao S, Wang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:139-147

Published Date: 17 January 2019

Metabolic syndrome as a risk factor for high intraocular pressure: the Korea National Health and Nutrition Examination Survey 2008–2010

Yi YH, Cho YH, Kim YJ, Lee SY, Lee JG, Kong EH, Cho BM, Tak YJ, Hwang HR, Lee SH, Park EJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:131-137

Published Date: 14 January 2019

Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes

Durán AM, Salto LM, Câmara J, Basu A, Paquien I, Beeson WL, Firek A, Cordero-MacIntyre Z, De León M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:109-120

Published Date: 8 January 2019

Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice

Campbell CL, Yu R, Li F, Zhou Q, Chen D, Qi C, Yin Y, Sun J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:97-107

Published Date: 4 January 2019

Initial outcomes of one anastomosis gastric bypass at a single institution

Jamal W, Zagzoog MM, Sait SH, Alamoudi AO, Abo’ouf S, Alghamdi AA, Bamashmous RO, Maghrabi AA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:35-41

Published Date: 24 December 2018